|
[1]葉美玲、陳婕穎、王珮棋、陳興夏,2011。運動改善更年期婦女骨質疏鬆之成效。醫護科技期刊。13(3):125-134。 [2]Cummings SR, and Melton LJ. 2002. Epidemiology and outcomes of osteoporosis fractures. Lancet 359:1761-1767. [3]Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, and Vogt TM. 1993. Bone density at various sites for prediction of hip fractures. The study of osteoporotic fractures research group. Lancet 341:72-75. [4]Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, and Breart G. 1996. Fall-related factors and risk of hip fracture: The EPIDOS prospective study. Lancet 348:145-149. [5]Faulkner KG, Cummings SR, Black D, Palermo L, Gluer CC, and Genant HK. 1993. Simple measurement of femoral geometry predicts hip fracture: The study of osteoporotic fractures. J. Bone Miner. Res. 8:1211-1217. [6]Yilmaz D, Ersoy B, Bilgin E, Gumuser G, Onur E, and Pinar ED. 2005. Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters. J. Bone Miner. Metab. 23:476-82. [7]Holbrook TL, Barrett-Connor E, and Wingard DL.1988. Dietary calcium and risk of hip fracture:14 year prospective population study. Lancet 2:1046-1049. [8]Law MR, and Hackshaw AK. 1997. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect. Br. Med. J. 315:841-846. [9]Feitelberg S, Epstein S, Ismail F, and D''Amanda C. 1987. Deranged bone mineral metabolism in chronic alcoholism. Metabolism 36:322-326. [10]Cooper C, Barker DJP, and Wickham C. 1988. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in britain. Br. Med. J. 297:1443-1446. [11]Junqueira LC, Carneiro J, and Kelley RO. 2000. Basic Histology, 9th edition. USA,356-398. [12]Stavros C, Manolagas, and Jilka RL. 2006. Bone marrow, cytokines, and bone remodeling, N. Engl. J. Med., 332(5):305-311. [13]Turek SL, 1984. Orthopaedics principles and their applications. J.B. Lippincott Company, Vol. 1, p. 31-100. [14]Zioupos P, and Currey JD, 1998. Changes in the stiffness, strength, and toughness of human cortical bone with age. Bone, Vol. 22 (1): 57-66. [15]Xiang A, Kanematsu A, Mitamura M, Kikkawa H, Asano S, and Kinoshita M. 2006. Analysis of change patterns of microcomputed tomography 3-dimensional bone parameters as a high-throughput tool to evaluate antiosteoporotic effects of agents at an early stage of ovariectomy-induced osteoporosis in mice. Invest. Radiol. 41(9):704-712. [16]楊榮森,1997。骨質疏鬆症:病因、診斷、治療。合計圖書出版社,台北市 p. 1-73, 261-267, 369-375. [17]Rubin MA, Jasiuk I, Taylor J, Rubin J. 2003. TEM analysis of the nanostructure of normal and osteoporotic human trabecular bone. Bone, 33: 270-282. [18]Somerville JM, Aspden RM, Armour KE, Armour KJ, and Reid DM. 2004. Growth of C57Bl/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif. Tissue Int., 74:469-475. [19]行政院衛生署國民健康局:骨質疏鬆症臨床治療指引。初版。台北市:行政院衛生署國民健康局,2011:89-92。 [20]Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P. 2010. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews Issue 7. [21]Max RE. 2003. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg, 61(9): 1115-7. [22]Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. 2010. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-conrol analysis winthin a UK primary care cohort. BMJ, 341: c4444. [23]Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, and Eastell R. 2002. Efficacy of raloxifene on vertebral fracture reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J. Clin. Endocrinol. Metab. 87(8): 3609-17. [24]McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Ph.D., and Bekker PJ. 2006. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354: 821-31. [25]Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, and Marriott TB. 2007. Effect of ecombinant human parathyroid hormone on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann. Intern. Med,146(5): 326-39. [26]Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP and Marcus R. 2007. Teriparatide or alendronate in glucocorticoid-induced osteoporosis, N Engl J Med, 357: 2028-39. [27]Hengsberger S, Ammann P, Legros B, Rizzoli R, and Zysset P. 2005. Intrinsic bone tissue properties in adult rat vertebrae:modulation by dietary protein", Bone, 36:134-141. [28]郭卿雲,2004。畜產食品科技另類的發酵乳克弗爾。科學發展。379:6-11。 [29]Narva M, Nevala R, Poussa T, and Korpela R. 2004. The effect of Lactobacillus helveticus fermented milk on acute changes in calcium metabolism in postmenopausal women. Eur. J. Nutr. 43:61-68. [30]Adolphi B, Scholz-Ahrens KE, De Vrese M, Acil Y, Laue C, Schrezenmeir J. 2009. Short-term effect of bedtime consumption of fermented milk supplemented with calcium, inulin-type fructans and caseinphosphopeptides on bone metabolism in healthy, postmenopausal women. Eur. J. Nutr, 48:45-53. [31]Chiu WY, Chien JY, Yang WS, Juang JM, Lee JJ, and Tsai KS. 2014. The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene. J. Clin. Endocrinol. Metab., 99(8): p. 2729-35. [32]Yamazaki T, Yamori M, Yamamoto K, Saito K, Asai K, Sumi E, Goto K, Takahashi K, Nakayama T, and Bessho K. 2012. Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: a hospital-based cohort study in Japan. Bone, 51(5): p. 882-7. [33]Green J, Czanner G, Reeves G, Watson J, and Wise L. 2010. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. Br. Med. J., 341: p. c4444. [34]Park-Wyllie, LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, and Laupacis A. 2011. Bisphosphonate use and the risk of subtrochanteric or femoral fractures in older women. JAMA, 305(8): p. 783-9. [35]Sugimoto M, Futaki N, Harada M, and Kaku S. 2013. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate. Bone, 52(1): p. 181-8. [36]Sakai A, Ito M, Tomomitsu T, Tsurukami H, Ikeda S, Fukuda F, Mizunuma H, Inoue T, Saito H, and Nakamura T. 2015. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis. Osteoporos. Int., 26(3): p. 1193-202. [37]Shao HB, Yao YM, Wang ZY, Zhang QF, and Wei W. 2015. Effects of combined alendronate and alfacalcidol on prevention of fractures in osteoporosis patients: a network meta-analysis. Int. J. Clin. Exp. Med., 8(8): p. 12935-41. [38]Sasaki H, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Kamo K, and Shimada Y. 2010. Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice. J. Bone Miner. Metab., 28(4): p. 403-9. [39]Altman AR, Tseng WJ, De-Bakker CMJ, Huh BK, Chandra A, Qin L, and Liu XS. 2014. A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment. Bone, 61: p. 149-57. [40]Guzel-Seydim ZB, Kok-Tas T, Greene AK, and Seydim AC. 2011. Review: functional properties of kefir. Crit. Rev. Food Sci. Nutr., 51(3): p. 261-8. [41]Chen HL, Tung YT, Chuang CH, Tu MY, Tsai TC, Chang SY, Chen CM. 2015. Kefir improves bone mass and microarchitecture in an ovariectomized rat model of postmenopausal osteoporosis. Osteoporos. Int., 26(2): p. 589-99. [42]Yoon KH, Cho DC, Yu SH, Kim KT, Jeon YH, Sung JK, 2012. The Change of Bone Metabolism in Ovariectomized Rats : Analyses of MicroCT Scan and Biochemical Markers of Bone Turnover. J Korean Neurosurg Soc, 51 : 323-327. [43]Tu MY, Chen HL, Tung YT, Kao CC, Hu FC, Chen CM. 2015.Short-term effects of kefir-fermented milk consumption on bone mineral density and bone metabolism in a randomized clinical trial of osteoporotic patients. PLOS One, 10(12): p. e0144231. [44]Braidotti P, Bemporad E, D''Alessio T, Sciuto SA, and Stagni L. 2000. Tensile experiments and SEM fractography on bovine subchondral bone. J. Biomech., 33.1153-1157.
|